Lv5
1400 积分 2022-11-04 加入
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
1个月前
已完结
Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China
1个月前
已完结
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC
1个月前
已完结
Molecular subtyping-guided precision therapy for ESCC: biomarker-driven strategies and clinical translation pathways
1个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for advanced or metastatic esophageal squamous cell carcinoma: A network meta-analysis
1个月前
已完结
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
1个月前
已完结
Human immune system variation
2个月前
已完结
Adaptive immune receptor repertoire analysis
2个月前
已完结
Standardisation and validation of an in-house quantitative real-time polymerase chain reaction (qPCR) assay for the diagnosis of Clostridioides difficile infection
3个月前
已完结
PARP7: an Emerging Therapeutic Target-Insights into Biological Functions and Advances in Small-Molecule Inhibitor Development
3个月前
已完结
皖公网安备34019202002308
